103 related articles for article (PubMed ID: 8638646)
1. Lack of B cells precursors in marrow transplant recipients with chronic graft-versus-host disease.
Storek J; Witherspoon RP; Webb D; Storb R
Am J Hematol; 1996 Jun; 52(2):82-9. PubMed ID: 8638646
[TBL] [Abstract][Full Text] [Related]
2. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
[TBL] [Abstract][Full Text] [Related]
3. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
[TBL] [Abstract][Full Text] [Related]
4. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D
Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.
Abrahamsen IW; Sømme S; Heldal D; Egeland T; Kvale D; Tjønnfjord GE
Haematologica; 2005 Jan; 90(1):86-93. PubMed ID: 15642674
[TBL] [Abstract][Full Text] [Related]
6. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
[TBL] [Abstract][Full Text] [Related]
8. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
[TBL] [Abstract][Full Text] [Related]
9. De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant .
Godder K; Pati AR; Abhyankar SH; Lamb LS; Armstrong W; Henslee-Downey PJ
Bone Marrow Transplant; 1997 Apr; 19(8):813-7. PubMed ID: 9134174
[TBL] [Abstract][Full Text] [Related]
10. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease.
Shimura K; Ashihara E; Shimazaki C; Matsunaga S; Taniguchi K; Uchiyama H; Matsumoto Y; Kimura S; Matsubara H; Taniwaki M; Maekawa T
Biol Blood Marrow Transplant; 2008 Apr; 14(4):426-37. PubMed ID: 18342785
[TBL] [Abstract][Full Text] [Related]
11. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
[TBL] [Abstract][Full Text] [Related]
12. Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A.
Liem LM; van Noort JT; Goulmy E
Bone Marrow Transplant; 1996 Jul; 18(1):73-8. PubMed ID: 8831998
[TBL] [Abstract][Full Text] [Related]
13. Immunohistopathological study of the oral lichenoid lesions of chronic GVHD.
Sato M; Tokuda N; Fukumoto T; Mano T; Sato T; Ueyama Y
J Oral Pathol Med; 2006 Jan; 35(1):33-6. PubMed ID: 16393251
[TBL] [Abstract][Full Text] [Related]
14. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
15. Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants.
Michonneau D; Peffault de Latour R; Porcher R; Robin M; Benbunan M; Rocha V; Ribaud P; Ferry C; Devergie A; Vanneaux V; Gluckman E; Marolleau JP; Socié G; Larghero J
Br J Haematol; 2009 Apr; 145(1):107-14. PubMed ID: 19183190
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
20. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
Morariu-Zamfir R; Rocha V; Devergie A; Socié G; Ribaud P; Esperou H; Parquet N; Guardiola P; Dal Cortivo L; Bittencourt H; Garnier F; Traineau R; Marolleau JP; Chevret S; Gluckman E
Bone Marrow Transplant; 2001 Mar; 27(6):575-80. PubMed ID: 11319585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]